PBS Newshour - September 17, 2019
Alan Shapiro, M.D., discusses the harmful physical and mental effects of detaining migrant children in government detention facilities. Dr. Shapiro is clinical assistant professor of pediatrics at Einstein and senior medical director of community pediatrics programs at Children's Hospital at Montefiore.
Dr. Shapiro's Profile
Science - September 16, 2019
Research by Paul Frenette, M.D., has advanced what we know about how nerves spur the development and spread of prostate cancer. His new research investigates how beta blockers, which target the nervous system, may help treat cancer. Dr. Frenette is professor of medicine and of cell biology, and chair and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.
Dr. Frenette's ProfileMore coverage on Dr. Frenette
The Scientist - September 10, 2019
David Q.H. Wang, M.D., Ph.D., details the limitations of a study that claims sticky clumps of DNA and protein extruded by immune cells help gallstones form. Dr. Wang is professor of medicine and of genetics at Einstein.
Dr. Wang's Profile
WSJ - August 19, 2019
Helena Blumen, Ph.D., describes her NIH-funded research on social dancing’s effects on the brain and its role as a potential intervention to reduce dementia risk. Dr. Blumen is assistant professor of medicine and in the Saul R. Korey Department of Neurology.
Dr. Blumen's Profile
Science - August 8, 2019
Harris Goldstein, M.D., describes his new research, in Science Translational Medicine, that uses genetically reprogrammed T cells to successfully fight HIV infection in mice. Dr. Goldstein is professor of pediatrics and of microbiology & immunology and director of the Einstein-Rockefeller-CUNY Center for AIDS Research.
Dr. Goldstein's ProfileMore coverage on Dr. Goldstein
The Atlantic - July 15, 2019
Eric Hollander, M.D., comments on how ingesting the eggs of the parasitic worm Trichuris suis may affect the gut microbiome and improve repetitive behavior, rigidity, and irritability in people with autism spectrum disorder. Dr. Hollander is professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Einstein and Montefiore.
Dr. Hollander's ProfileMore coverage on Dr. Hollander
CBS New York - July 12, 2019
Richard Lipton, M.D., discusses his New England Journal of Medicine study on rimegepant, a drug belonging to a new generation of acute migraine headache treatments that was found to eliminate pain and reduce bothersome symptoms. Dr. Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein and director of the Montefiore Headache Center.
More Coverage on this Story
US News & World Report (via HealthDay)
Dr. Lipton's ProfileMore coverage on Dr. Lipton
UPI - July 3, 2019
Paul Frenette, M.D., explains his research on a beta blocker that significantly reduced men’s risk of intermediate- and low-grad prostate cancer. Dr. Frenette is professor of medicine and of cell biology, and chair and director of the Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research.
Dr. Frenette's ProfileMore coverage on Dr. Frenette
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is chair of ophthalmology & vision services at Einstein and Montefiore Medical Center.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
More coverage on
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder